High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients - 26/11/20
, Jie Zhang a, 1, Lifei Liu b, 1, Xiaodong Yuan a, Xuefeng Zang a, Feiping Lu a, Ping He c, Qian Wang c, Xiaomeng Zhang c, Yimin Xu a, Xiang Li a, Ying Liu a, Qun Li a, Xuebing Tan a, Yunhui Zheng a, Xue Lin a, Yuhang Liu a
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Abstract |
Objective |
There were COVID-19 patients with SARS-COV-2 nucleic acid long-term positive. This article aims to understand the relevant factors that affect SARS-COV-2 clearance time.
Methods |
The clinical data of 115 COVID-19 patients with SARS-COV-2 nucleic acid positive time exceeding 14 days were collected retrospectively, and the relationship between clinical characteristics, chest CT scans, blood cells, biochemical indicators, and the time of viral nucleic acid turning negative were analyzed.
Results |
The time from symptom onsets to nucleic acid turning negative was (32.5 ± 8.7) days in this group of patients. The time of nucleic acid turning negative: no fever group was longer than fever group, diabetes group was longer than no comorbidity group, elevated levels of ALT (alanine aminotransferase), or GLU (fasting blood glucose) group, decreased levels of ALB (albumin) group or HDLC (high-density lipoprotein cholesterol) group was longer than it's normal group separately (P < 0.05). Cox multivariate regression analysis showed that ALT [odds ratio (OR): 2.164 (95% CI: 1.276–3.670), P = 0.004], GLU [OR: 2.064 (95% CI: 1.195–3.566), P = 0.009] and HDLC [OR: 0.527 (95% CI: 0.307–0.907), P = 0.021] were independent factors which affected the time of nucleic acid turning negative.
Conclusions |
ALT, GLU and HDLC were independent factors that influenced the time of nucleic acid turning negative. Although diabetes or hyperglycemia is a known risk factor, HDLC is the first to be identified, clinicians should be aware of dyslipidemia in covid-19 patients.
Il testo completo di questo articolo è disponibile in PDF.Highlights |
• | There were some COVID-19 patients whose virus clearance time exceeded 15 days. |
• | Liver damage and hyperglycemia are risk factors that prolong virus clearance time. |
• | Some COVID-19 Patients have abnormal lipid metabolism. |
• | Reduced HDLC was a risk factor contributing to the prolonged virus clearance time. |
Keywords : High-density lipoprotein cholesterol, SARS-COV-2, COVID-19, Virus clearance time, Risk factors
Mappa
Vol 175
Articolo 106218- dicembre 2020 Ritorno al numero
Articolo precedente
- Determining extent of COVID-19 pneumonia on CT based on biological variables
- Mickael Tordjman, Ahmed Mekki, Rahul D. Mali, Hippolyte Monnier, Sophie Neveu, Guillaume Chassagnon, Fadila Mihoubi, Nicolas Carlier, Jonathan Marey, Laure Fournier, Robert-Yves Carlier, Jean-Luc Drapé, Marie-Pierre Revel
- Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy
- Alessandro Torre, Stefano Aliberti, Paola Francesca Castellotti, Daniela Maria Cirillo, Antonella Grisolia, Davide Mangioni, Giulia Marchetti, Roberto Rossotti, Pierachille Santus, Giorgio Besozzi, Simone Villa, Luigi Ruffo Codecasa, Milan TB-COVID-19 study group, Alessandra Bandera, Francesco Blasi, Daniela Campisi, Maurizio Ferrarese, Andrea Gramegna, Alessandra Lombardi, Alessandro Mancon, Marco Mantero, Antonio Muscatello, Matteo Passerini, Marco Piscaglia, Matteo Saporiti, Marco Schiuma
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.